Company Filing History:
1 out of 63 
1 out of 23 
1 out of 30 
Years Active: 2019-2022
Title: Georg Gdynia: Innovator in Cancer Treatment
Introduction
Georg Gdynia is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of cancer. With a total of three patents to his name, Gdynia's work focuses on innovative approaches to combat inappropriate cellular proliferation.
Latest Patents
Gdynia's latest patents include groundbreaking inventions that target cancer treatment. One of his notable patents is for a combined preparation of PKM2 modulators and HMGB1. This invention relates to a combined preparation that includes a modulator of pyruvate kinase M2 (PKM2) activity and an agent providing high mobility group box 1 (HMGB1) polypeptide. This combined preparation is intended for use as a medicament in treating inappropriate cellular proliferation, particularly cancer. Another significant patent involves HMGB1 tyrosine mutants, which focuses on a high mobility group box 1 (HMGB1) polypeptide with specific amino acid exchanges. This invention also encompasses a polynucleotide encoding the polypeptide, along with related methods and kits.
Career Highlights
Throughout his career, Georg Gdynia has worked at prestigious institutions, including Ruprecht-Karls-Universität Heidelberg. His research and innovations have contributed to advancements in medical treatments, particularly in oncology. Gdynia's work exemplifies the intersection of scientific research and practical application in medicine.
Collaborations
Some of Gdynia's notable coworkers include Wilfried Roth and Sven Sauer. Their collaborative efforts have further enhanced the impact of Gdynia's inventions in the medical field.
Conclusion
Georg Gdynia stands out as an influential inventor in the realm of cancer treatment. His innovative patents and contributions to medical science reflect his commitment to improving patient outcomes. Gdynia's work continues to inspire advancements in the treatment of cancer and inappropriate cellular proliferation.